v3 Template
M

MEI Pharma, Inc.

Biotechnology/Pharmaceuticals
Founded
--
Employees
--
Total Funding
$309.3M
Funding Rounds
4
Last Funding
2025-07-22

About MEI Pharma, Inc.

MEI Pharma is dedicated to developing novel and differentiated cancer therapies aimed at overcoming drug resistance mechanisms and improving patient outcomes through combination with standard-of-care therapies. Their mission is focused on delivering benefits to patients with a patient-centric approach.

Products & Services

Voruciclib:A program in the pipeline focused on cancer therapy development.
Clinical Trials:Ongoing clinical trials for testing cancer therapies.

Specialties

Cancer Therapies Hematologic Malignancies Solid Tumors Drug Resistance Mechanisms

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: PIPE
T: -
FT: PIPE 		A: 100000000
MR: -
FA: $100,000,000
FAN: 100000000 		D: 2025-07-22
FD: 2025-07-22 		9 investors
2 RT: PIPE (Private Investment in Public Equity)
T: -
FT: PIPE (Private Investment in Public Equity) 		A: 100000000
MR: -
FA: $100,000,000
FAN: 100000000 		D: 2025-07-18
FD: 2025-07-18 		10 investors
3 RT: PIPE
T: -
FT: PIPE 		A: 100000000
MR: -
FA: $100 million
FAN: 100000000 		D: 2025-07-18
FD: 2025-07-18 		10 investors
4 RT: Other (Capital Return Agreement)
T: -
FT: Other (Capital Return Agreement) 		A: 9330000
MR: -
FA: Approximately $9.33 million for second return of capital
FAN: 9330000 		D: 2023-11-01
FD: 2023-11-01 		2 investors
PIPE Latest
2025-07-22
$100.0M
9 investors (Pro only)
PIPE (Private Investment in Public Equity) 2025-07-18
$100.0M
PIPE 2025-07-18
$100.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

MEI Pharma, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Pharmaceuticals

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro